CD44 and type 2 diabetes mellitus: While this manuscript was in preparation, an expression-based genome-wide association (eGWAS) study linked CD44 to type 2 diabetes in humans and reported that CD44-deficiency ameliorates insulin resistance in mice and humans [21].